SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001013762-24-002110
Filing Date
2024-07-29
Accepted
2024-07-29 16:30:56
Documents
7

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0209752-s1_virpaxphar.htm S-1 535222
2 CONSENT OF EISNERAMPER LLP ea020975201ex23-1_virpaxphar.htm EX-23.1 2221
3 FILING FEE TABLE ea020975201ex-fee_virpaxphar.htm EX-FILING FEES 58211
4 GRAPHIC image_001.jpg GRAPHIC 6908
5 GRAPHIC image_002.jpg GRAPHIC 39354
6 GRAPHIC image_003.jpg GRAPHIC 34687
7 GRAPHIC image_004.jpg GRAPHIC 3729
  Complete submission text file 0001013762-24-002110.txt   713928
Mailing Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312
Business Address 1055 WESTLAKES DRIVE, SUITE 300 BERWYN PA 19312 610-727-4597
Virpax Pharmaceuticals, Inc. (Filer) CIK: 0001708331 (see all company filings)

IRS No.: 821510982 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-281080 | Film No.: 241152845
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)